Q1 2025

Source filing unavailable

Q1 2025 · —

Revenue

$553.82K

no prior Q1 2024 on file

Net Income

-$764.58K

no prior Q1 2024 on file

EPS Diluted

-$0.16

no prior Q1 2024 on file

Gross Profit$165,795—

Operating Income-$772,180—

Operating Cash Flow-$488,293

Same quarter

no prior Q1 2024 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

20/20 Biolabs, Inc. · CIK 1139685 · Engraved from SEC EDGAR